The foremost life sciences business network event in the Netherlands
The Netherlands is home to 2,900 innovative Life Sciences businesses, including 420 biopharmaceutical companies, and the European Medicines Agency, making it one of the most concentrated Life Sciences and Health clusters in the world. About 770 clinical trials are currently active in the Netherlands and the country boasts a competitive international business climate which is reflected by its status as the sixth-largest EY economy, a major global exporter and importer of goods and a Forbes ranking as the third best country for doing business. Together with a very strong scientific background it makes the Dutch industry a major European player with great economic- and societal impact. The Dutch Life Sciences conference is hosted by organisations and companies whose mission is to help realize the further development and growth of the Dutch life sciences industry.
The 15th edition of the Dutch Life Sciences conference will take place at the Leiden Bio Science Park on November 28th, 2019. The conference inspires and promote an open exchange of information including trends and developments in the industry.
The programme consists of plenary sessions and parallel sessions, an investors forum, active networking possibilities and an information market. In addition the winner of the Venture Challenge Award will be announced.
Advisory committee 2018
- Harrold van Barlingen, Managing Director Thuja Capital
- Carine van den Brink, Partner Axon Lawyers
- Jos Joore, Managing Director Mimetas
- John de Koning, Partner LSP
- Leon Mur, Director Iventus
- Ernst Nagel, Operations Director Health~Holland
- André van de Sande, CEO Xendo
- Onno van de Stolpe, Chief Executive Officer Galapagos NV